Sameh Tawfik

Array ( [id] => 10176230 [patent_doc_number] => 09206425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-08 [patent_title] => 'Methods for treating Niemann-Pick type C disease' [patent_app_type] => utility [patent_app_number] => 14/235482 [patent_app_country] => US [patent_app_date] => 2012-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7230 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662326 [patent_doc_number] => 08809294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Method of inhibiting miR-33 using a modified oligonucleotide' [patent_app_type] => utility [patent_app_number] => 13/540097 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 136678 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13540097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9462732 [patent_doc_number] => 20140127159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'HCV Combination Therapy' [patent_app_type] => utility [patent_app_number] => 14/128504 [patent_app_country] => US [patent_app_date] => 2012-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26837 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9635524 [patent_doc_number] => 20140213632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'HCV Combination Therapy' [patent_app_type] => utility [patent_app_number] => 14/128508 [patent_app_country] => US [patent_app_date] => 2012-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26725 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442272 [patent_doc_number] => 20120258888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'siRNA Targeting Proto-oncogene MET' [patent_app_type] => utility [patent_app_number] => 13/494360 [patent_app_country] => US [patent_app_date] => 2012-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 35026 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464715 [patent_doc_number] => 20120269883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'MicroRNA-140-5P as a Tumor Suppressor and Sensitizing Agent for Chemotherapy' [patent_app_type] => utility [patent_app_number] => 13/453553 [patent_app_country] => US [patent_app_date] => 2012-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14862 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406549 [patent_doc_number] => 20120238618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides' [patent_app_type] => utility [patent_app_number] => 13/415685 [patent_app_country] => US [patent_app_date] => 2012-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 39595 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13415685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11263492 [patent_doc_number] => 09487778 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Oligonucleotide modulators of the toll-like receptor pathway' [patent_app_type] => utility [patent_app_number] => 14/002901 [patent_app_country] => US [patent_app_date] => 2012-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45899 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442382 [patent_doc_number] => 20120258999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Reagents, Methods and Systems to Suppress Pro-Inflammatory Cytokines' [patent_app_type] => utility [patent_app_number] => 13/369419 [patent_app_country] => US [patent_app_date] => 2012-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6854 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13369419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10038216 [patent_doc_number] => 09078911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Antisense oligonucleotides' [patent_app_type] => utility [patent_app_number] => 13/369050 [patent_app_country] => US [patent_app_date] => 2012-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9253 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13369050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8198622 [patent_doc_number] => 20120122216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS' [patent_app_type] => utility [patent_app_number] => 13/359271 [patent_app_country] => US [patent_app_date] => 2012-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 136657 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122216.pdf [firstpage_image] =>[orig_patent_app_number] => 13359271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8607138 [patent_doc_number] => 20130012450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Dermatology Related Genetic Diseases' [patent_app_type] => utility [patent_app_number] => 13/356363 [patent_app_country] => US [patent_app_date] => 2012-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9774 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13356363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289382 [patent_doc_number] => 20120177701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'COMPOSITIONS COMPRISING IMMUNOSTIMULATORY NUCLEIC ACIDS AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 13/341325 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 35525 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13341325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8183998 [patent_doc_number] => 20120114607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES' [patent_app_type] => utility [patent_app_number] => 13/333882 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 19252 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114607.pdf [firstpage_image] =>[orig_patent_app_number] => 13333882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8981880 [patent_doc_number] => 08512994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA' [patent_app_type] => utility [patent_app_number] => 13/301204 [patent_app_country] => US [patent_app_date] => 2011-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 17466 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13301204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199615 [patent_doc_number] => 20120122963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA' [patent_app_type] => utility [patent_app_number] => 13/301147 [patent_app_country] => US [patent_app_date] => 2011-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17441 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122963.pdf [firstpage_image] =>[orig_patent_app_number] => 13301147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818478 [patent_doc_number] => 20120065098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21' [patent_app_type] => utility [patent_app_number] => 13/296545 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 39101 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065098.pdf [firstpage_image] =>[orig_patent_app_number] => 13296545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8055955 [patent_doc_number] => 20120077699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-103-2' [patent_app_type] => utility [patent_app_number] => 13/296291 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 38603 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077699.pdf [firstpage_image] =>[orig_patent_app_number] => 13296291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807960 [patent_doc_number] => 20120058914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'METHOD OF DIAGNOSING POOR SURVIVAL PROGNOSIS COLON CANCER USING miR-203' [patent_app_type] => utility [patent_app_number] => 13/296371 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 38599 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058914.pdf [firstpage_image] =>[orig_patent_app_number] => 13296371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571462 [patent_doc_number] => 08338106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Method of diagnosing poor survival prognosis colon cancer using miR-29a' [patent_app_type] => utility [patent_app_number] => 13/296448 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 38603 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13296448 [rel_patent_id] =>[rel_patent_doc_number] =>)